Unbound MEDLINE

Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease (GORD): the GORD-QOL questionnaire. Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] Journal article

 
TitleDevelopment and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease (GORD): the GORD-QOL questionnaire.
Author(s)Chan Y, Ching JY, Cheung CM, Tsoi KK, Polder-Verkiel S, Pang SH, Quan WL, Kee KM, Chan FK, Sung JJ, Wu JC 
InstitutionInstitute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
SourceAliment Pharmacol Ther 2009 Oct 31.
AbstractAbstract
Background: A simple and meaningful health-related quality of life (HRQoL) questionnaire for gastro-oesophageal reflux disease (GORD) patients is lacking.
Aim: To develop and validate a disease-specific HRQoL instrument (GORD-QOL) for GORD patients.
Methods: An 18-item questionnaire was generated to measure the impact of GORD on sleep, exercise, diet, need of medication, sex life, work, social activity and psychological well-being. GORD patients were invited to complete the GORD-QOL, a visual analogue scale (VAS) and a validated Chinese generic QoL (SF-36) questionnaire before and after esomeprazole treatment. Factor analysis was performed for item selection and psychometric properties were measured. An English version was developed by a forward-backward translation process.
Results: A final 16-item GORD-QOL questionnaire was developed. The items were grouped into 4 subscales (Daily activity, Treatment effect, Diet, and Psychological well-being) after factor analysis. GORD-QOL had good item-internal consistency (Cronbach's alpha: 0.64-0.88), high test-retest reliability (intraclass correlation coefficient: 0.73-0.94, p<0.001). Its subscale scores were correlated with SF-36 and VAS, which demonstrated high construct validity (p<0.001). Discriminant validity was verified by correlating GORD-QOL scores with symptom severity (p<0.001). Responsiveness after esomeprazole treatment was significant (paired-t-test p<0.001). An English version of GORD-QOL was developed.
Conclusion: GORD-QOL is a valid and reliable instrument.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19878152
  
Advertise on this site.